Stephan Herbertz
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Cancer-related gene regulation 3
- Glycosylation and Glycoproteins Research 3
- Ubiquitin and proteasome pathways 2
- Oncology 7
- Peptidase Inhibition and Analysis 3
- Lung Cancer Research Studies 2
- Co-authors
- Jon Zugazagoitia (1 shared paper)Ivelina Gueorguieva (1 shared paper)Kyla Driscoll (1 shared paper)Shawn T. Estrem (1 shared paper)Gerald Schmid‐Bindert (1 shared paper)Karim A. Benhadji (1 shared paper)Luis Paz‐Ares (1 shared paper)Ann Cleverly (1 shared paper)
- Journals
- Genes Chromosomes and Cancer (2 papers)Journal of Thoracic Oncology (1 paper)Lung Cancer (1 paper)Journal of Cancer Research and Clinical Oncology (1 paper)Drug Design Development and Therapy (1 paper)
- Partner nations
- GermanyUnited KingdomDenmark
In The Last Decade
Stephan Herbertz
10 papers receiving 1.1k citations
Stephan Herbertz's Hit Papers
Peers
Comparison fields: 5 of 100
- Oncology 426
- Cancer Research 195
- Immunology 205
- Molecular Biology 584
- Pulmonary and Respiratory Medicine 245
Countries citing papers authored by Stephan Herbertz
This map shows the geographic impact of Stephan Herbertz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan Herbertz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan Herbertz more than expected).
Fields of papers citing papers by Stephan Herbertz
This network shows the impact of papers produced by Stephan Herbertz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan Herbertz. The network helps show where Stephan Herbertz may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephan Herbertz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway Hit paper breakdown → | 2015 | 453 |
| 2 | 2018 | 229 | |
| 3 | DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer. | 2000 | 153 |
| 4 | Deleted in Malignant Brain Tumors 1 is a versatile mucin-like molecule likely to play a differential role in digestive tract cancer. | 2001 | 80 |
| 5 | 1999 | 72 | |
| 6 | 2002 | 53 | |
| 7 | 2002 | 36 | |
| 8 | 2011 | 6 | |
| 9 | 2024 | 1 | |
| 10 | 2024 | 1 |
About Stephan Herbertz
Stephan Herbertz is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Immunology and Pathology and Forensic Medicine, having authored 10 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (4 papers), Cancer-related gene regulation (3 papers), Glycosylation and Glycoproteins Research (3 papers), Peptidase Inhibition and Analysis (3 papers), Galectins and Cancer Biology (2 papers), Lung Cancer Research Studies (2 papers), Ubiquitin and proteasome pathways (2 papers) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Oncology (426 citations), Cancer Research (195 citations), Immunology (205 citations), Molecular Biology (584 citations) and Pulmonary and Respiratory Medicine (245 citations). Stephan Herbertz has collaborated with scholars based in Germany, United Kingdom and Denmark. Frequent co-authors include Jon Zugazagoitia, Ivelina Gueorguieva, Kyla Driscoll, Shawn T. Estrem, Gerald Schmid‐Bindert, Karim A. Benhadji, Luis Paz‐Ares, Ann Cleverly, Susan C. Guba and Christopher A. Slapak. Their work appears in journals such as Genes Chromosomes and Cancer, Journal of Thoracic Oncology, Lung Cancer, Journal of Cancer Research and Clinical Oncology and Drug Design Development and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.